Author

Jim Swildens

ProQR Therapeutics (Netherlands)ORCID 0000-0001-7793-8580Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andrew R. WebsteriD· 1 shared Davide PiccoloiD· 1 shared Gerard J. PlatenburgiD· 1 shared Kalyan Dulla· 1 shared Melita KaltakiD· 1 shared Michael E. CheethamiD· 1 shared Petra de Bruijn· 1 shared Rob W.J. ColliniD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Andrew R. WebsterORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular BiologybioRxivPreprintAug 12, 2022

Antisense oligonucleotide therapy for the common Stargardt disease type 1-causing variant in ABCA4

Melita Kaltak, Petra de Bruijn, Davide Piccolo…·Jim Swildens

This study demonstrates that antisense oligonucleotides can correct splicing defects in the ABCA4 c.5461-10T>C variant, restoring protein function in retinal organoids.

1 citation

humanexperimental assay

𝕏 PostBluesky